(Q37857587)

24 August 2017

1 reference

title

Heart failure highlights in 2010. (English)

1 reference

24 August 2017

0 references

2

Alexander H Maass

1 reference

24 August 2017

Kevin Damman

1

1 reference

PubMed ID

21436361

24 August 2017

Peter van der Meer

series ordinal

3

1 reference

24 August 2017

1 April 2011

1 reference

European Journal of Heart Failure

24 August 2017

1 reference

24 August 2017

13

1 reference

24 August 2017

4

1 reference

24 August 2017

358-363

1 reference

The transcription factor GATA-6 regulates pathological cardiac hypertrophy

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

CIB1 is a regulator of pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Vitamin D biology in heart failure: molecular mechanisms and systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with hear

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Food-restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Functional effects of glucose transporters in human ventricular myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

A map of human genome variation from population-scale sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Bone marrow dysfunction in chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Abnormal liver function in relation to hemodynamic profile in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Telemonitoring in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Cardiac-resynchronization therapy for mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

An entirely subcutaneous implantable cardioverter-defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

2010 Focused Update of ESC Guidelines on device therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

The prognostic importance of lung function in patients admitted with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR025

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFR025

1 reference

24 August 2017

1 reference

PubMed ID

21436361